KOSDAQ · Healthcare · ₩13B
₩1,6510.00%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 0.0% · as of 26.10.28
Among 34 바이오 peers
Quarterly Revenue Growth
“치료제 개발은 진전됐고, 이제 계약 성사가 다음 단계예요.”
In the company's words · 2026 2분기 filing